Literature DB >> 26678503

Cloning of two LIMCH1 isoforms: characterization of their distribution in rat brain and their agmatinase activity.

David García1, Patricio Ordenes2, José Benítez3, Arlette González3, María A García-Robles2, Vasthi López4, Nelson Carvajal3, Elena Uribe5.   

Abstract

Agmatine, a precursor for polyamine biosynthesis, is also associated with neurotransmitter, anticonvulsant, antineurotoxic and antidepressant actions in the brain. This molecule results from the decarboxylation of L-arginine by arginine decarboxylase, and it is hydrolyzed to urea and putrescine by agmatinase. Recently, we have described a new protein that also hydrolyzes agmatine, agmatinase-like protein (ALP), which was identified through immunohistochemical analysis in the hypothalamus and hippocampus of rats. However, its sequence differs greatly from all known agmatinases and does not contain the typical Mn(2+) ligands associated with the urea hydrolase family of proteins. ALP has a LIM-like domain close to its carboxyl terminus, and the removal of which results in a truncated variant with a tenfold increased k cat value and a threefold decreased K m value for agmatine. Analysis of the gene database revealed several transcripts, denominated LIMCH1 isoforms, with extreme 3' sequences identical to ALP. Limch1 gene products have been described as members of a multi-domain family of proteins with the biggest isoform containing a calponin homology (CH) domain at its N-terminus. Here, we cloned two LIMCH1 transcripts, one of 3177 bp and the other of 2709 bp (ALP contains 1569 bp) and analyzed LIMCH1 expression and distribution in rat brain using RT-PCR, Western blot and immunohistochemical analyses. LIMCH1 was detected mainly in the hypothalamic and hippocampal regions, which is similar to the distribution of ALP and agmatine in brain. In addition, we cloned and expressed both isoforms in E. coli and confirmed that they were catalytically active on agmatine with kinetic parameters similar to ALP. LIM domain-truncated variants of both isoforms moderately increased the k cat and catalytic efficiency. Thus, we propose that LIMCH1 is useful to regulate the intracellular concentrations of the neurotransmitter/neuromodulator, agmatine.

Entities:  

Keywords:  Agmatine; Hypothalamus; LIM domain; LIMCH1

Mesh:

Substances:

Year:  2015        PMID: 26678503     DOI: 10.1007/s00418-015-1389-0

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  31 in total

Review 1.  The LIM domain: from the cytoskeleton to the nucleus.

Authors:  Julie L Kadrmas; Mary C Beckerle
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

2.  Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus.

Authors:  Sanjay K Mistry; Tim J Burwell; Rebecca M Chambers; Laura Rudolph-Owen; Frank Spaltmann; W Jim Cook; Sidney M Morris
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-02       Impact factor: 4.052

3.  Further insight into the inhibitory action of a LIM/double zinc-finger motif of an agmatinase-like protein.

Authors:  Jaime Cofre; Paola Montes; Alejandro Vallejos; José Benítez; David García; José Martínez-Oyanedel; Nelson Carvajal; Elena Uribe
Journal:  J Inorg Biochem       Date:  2013-12-25       Impact factor: 4.155

4.  Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence.

Authors:  Fei Li; Ning Wu; Ruibin Su; Ying Chen; Xinqiang Lu; Yin Liu; Jin Li
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

5.  Expression of arginine decarboxylase in brain regions and neuronal cells.

Authors:  Abiye H Iyo; Meng-Yang Zhu; Gregory A Ordway; Soundar Regunathan
Journal:  J Neurochem       Date:  2006-02       Impact factor: 5.372

Review 6.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 7.  Agmatine: clinical applications after 100 years in translation.

Authors:  John E Piletz; Feyza Aricioglu; Juei-Tang Cheng; Carolyn A Fairbanks; Varda H Gilad; Britta Haenisch; Angelos Halaris; Samin Hong; Jong Eun Lee; Jin Li; Ping Liu; Gerhard J Molderings; Ana Lúcia S Rodrigues; Joseph Satriano; Gong Je Seong; George Wilcox; Ning Wu; Gad M Gilad
Journal:  Drug Discov Today       Date:  2013-06-13       Impact factor: 7.851

8.  Alternative splicing for members of human mosaic domain superfamilies. I. The CH and LIM domains containing group of proteins.

Authors:  Felix Friedberg
Journal:  Mol Biol Rep       Date:  2008-06-16       Impact factor: 2.316

9.  Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B.

Authors:  Won Taek Lee; Samin Hong; Sung Hwan Yoon; Jae Hwan Kim; Kyung Ah Park; Gong Je Seong; Jong Eun Lee
Journal:  Brain Res       Date:  2009-05-22       Impact factor: 3.252

10.  Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain.

Authors:  Chin Hee Mun; Won Taek Lee; Kyung Ah Park; Jong Eun Lee
Journal:  Anat Cell Biol       Date:  2010-09-30
View more
  2 in total

1.  Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.

Authors:  Terry Jo V Bichell; Michal Wegrzynowicz; K Grace Tipps; Emma M Bradley; Michael A Uhouse; Miles Bryan; Kyle Horning; Nicole Fisher; Karrie Dudek; Timothy Halbesma; Preethi Umashanker; Andrew D Stubbs; Hunter K Holt; Gunnar F Kwakye; Andrew M Tidball; Roger J Colbran; Michael Aschner; M Diana Neely; Alba Di Pardo; Vittorio Maglione; Alexander Osmand; Aaron B Bowman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

2.  Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals.

Authors:  María-Belen Reyes; José Martínez-Oyanedel; Camila Navarrete; Erika Mardones; Ignacio Martínez; Mónica Salas; Vasthi López; María García-Robles; Estefania Tarifeño-Saldivia; Maximiliano Figueroa; David García; Elena Uribe
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.